Answering T.T.P. (Thrombotic Thrombocytopenic Purpura) Foundation
Public foundation · Bailieboro, Ontario · BN 846004802RR0001 · Foundations · website
Source: T3010 return, FPE 2024-06-30. Split of total expenditures ($522,854) as filed with the CRA.
Answering T.T.P. (Thrombotic Thrombocytopenic Purpura) Foundation is a public foundation based in Bailieboro, Ontario, classified by the CRA under foundations. In its fiscal year ending June 30, 2024, it reported $48K in revenue and $523K in expenditures. Spending exceeded revenue that year — the gap came out of reserves.
Its funding that year was roughly 71% from donations, 7% from other charities. In 2024, 4 other registered charities reported granting it a combined $794.
Compared with 3,025 grantmaking charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 65% of peers. Its fundraising cost per donated dollar was lower than 82% of that peer group.
As a grantmaker, it reported gifts to 1 qualified donee totalling $120K in 2024, the largest being $120K to Canadian Organization for Rare Disorders (cord). Revenue has declined over its filings on record here, from $159K in 2020 to $48K in 2024. Its filed list of directors and trustees shows 6 names.
In its own words
Answering TTP Foundation provides research grants for TTP biomedical clinical and population health research. We provide patient support to alleviate the feeling of isolation that accompanies the diagnosis of a rare disorder. We connect the TTP community via our website and newsletters to facilitate patient to patient support by sharing experiences and education about TTP. We maintain a consolidated information platform to disseminate information to the geographically dispersed community. We develop TTP education materials to educate TTP patients the public and the medical community.
Ongoing-program description from its T3010 filing, verbatim.
The ledger, 2020–2024
| Year | Revenue | Spending | Programs | Fundraising | Gifts out | Net assets |
|---|---|---|---|---|---|---|
| 2024 | $48K | $523K | $514K | $196 | — | $1,089 |
| 2023 | $107K | $283K | $269K | $1,193 | — | $476K |
| 2022 | $189K | $15K | $1,453 | $2,095 | — | $652K |
| 2021 | $248K | $128K | $89K | $3,996 | — | $478K |
| 2020 | $159K | $119K | $105K | $2,692 | — | $358K |
Revenue printed in red where the year ran a deficit. Fiscal years by period end.
Money between charities, 2024
Granted $120K to 1 qualified donee:
Received $794 from 4 charities:
As reported on the donors’ own T3010 qualified-donee schedules.
Directors & trustees (2024)
Sydney Kodatsky (chair); Tammy Robertson (executive director); Lee Chung-Hae (grant director); Gergana Sandeva; Mina Rajan (director of patient relations); Maria Connell (treasurer).
As listed on its 2024 return.
Check the source
Every figure on this page is from Answering T.T.P. (Thrombotic Thrombocytopenic Purpura) Foundation’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 846004802RR0001), or read how we compute the receipt.